.png "back to home page")
FDA says Novartis knew its application for $2.1 million gene therapy included errors https://t.co/EdeB9unC3t
— ??”MAGA MAN”?? (@GhostTrumps) August 6, 2019
https://t.co/qDztBtQg2H
— Karolien Haese (@Karolien1231) August 6, 2019
Just a few weeks after approval, the most expensive drug in the word is questionned by the FDA In the near future crosschecking & data control will make cheating rather impossible. @dr_wardsam @numerikare @DigitalHealthBE @B_Hf_T
...well this hurts more than $NVS....https://t.co/HQAUlGFSuO
— Cole T.F. Roberts (@ColeTFR) August 6, 2019
#Novartis caught manipulating study data to get "the most expensive drug in the world" approved https://t.co/nGey1LAwoV
— HighWire (@HighWireTalk) August 6, 2019
FDA: Novartis knew of manipulation of data supporting Zolgensma approval by @adamfeuerstein https://t.co/08p79TkGzV
— Matthew Herper (@matthewherper) August 6, 2019
Novartis was aware of manipulation of data supporting gene therapy approval, FDA says https://t.co/FkJD9sc6jP $NVS
— Adam Feuerstein (@adamfeuerstein) August 6, 2019
BREAKING: Novartis was aware of manipulation of data supporting gene therapy approval, FDA says https://t.co/nEDtHPiT2C
— STAT (@statnews) August 6, 2019
?
— Sek Kathiresan MD (@skathire) August 6, 2019
Novartis was aware of manipulation of data supporting gene therapy approval, FDA says https://t.co/JC0eEEMvtm via @statnews
Remember the world’s most expensive drug in history receiving FDA approval in May 2019? $2.1M for a SINGLE infusion. Lots more to story: Novartis manipulated data in its application & delayed telling FDA until AFTER it was approved ▶️https://t.co/MXoATr35EV#BigPharma #cdnhealth https://t.co/6Jo9QAgoLs
— Kulvinder Kaur MD (@dockaurG) August 7, 2019
Novartis concealed its manipulated data from the FDA while applying for approval of its extremely expensive gene therapy treatment.
— Carl Elliott (@FearLoathingBTX) August 6, 2019
https://t.co/BlwvXD9mAO
"The drug maker Novartis concealed manipulated data from the Food and Drug Administration while applying for approval of an extremely expensive gene therapy treatment and then delayed reporting the issue, the agency said on Tuesday." https://t.co/m2n1TgGmsD By @katie_thomas
— Leigh Turner (@LeighGTurner) August 6, 2019
"Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment" by KATIE THOMAS via NYT https://t.co/EtymcOJc8Q
— Scott McKibbin (@McKibbinGroup) August 6, 2019
Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment https://t.co/IwMDyCxOni
— (((Jody Ranck))) (@jranck) August 6, 2019
I am sad to say, I'm nearly 100% confident this is not only example of manipulation of data submitted to the FDA.
— Venk Murthy (@venkmurthy) August 7, 2019
Only fix is to mandate trial data sharing.@jamesheathers @RetractionWatch@thebyrdlab @rwyeh @bnallamo @VPrasadMDMPH @hmkyalehttps://t.co/TIid7T3SEq
This is absolutely horrendous. But it’s worth noting how much these proven real-world BigPharma conspiracies fall from the hiding-the-cure-for-cancer-and-keeping-ppl-sick-for-profit-level where the internet conspiracy theories are at https://t.co/vRmaRyeI29
— Pauli Ohukainen (@POhukainen) August 7, 2019
Novartis was aware of manipulation of data supporting gene therapy approval, FDA says https://t.co/0MOdXssmD0 via @statnews
— Gideon Gil (@GideonGil) August 6, 2019
Novartis was aware of manipulation of data supporting gene therapy approval, FDA says https://t.co/VlUJe0pdqB via @statnews
— Ben Hirschler (@reutersBenHir) August 7, 2019
When Zolgensma arrived on the market with the highest price ever seen, most pharma policy experts took for granted that this expensive drug stood on solid data. We were wrong.
— Marc-André Gagnon (@MA_Gagnon) August 6, 2019
Novartis was aware of manipulation of data supporting Zolgensma approval https://t.co/QpjDD9d4b1
More #bigpharma wrongdoing, this time manipulating data which may lead to “civil or criminal penalties”.
— Judea Johnson (@judeajohnson) August 6, 2019
No product made by any of the criminal pharma companies should ever be mandated!#InformedConsent #SB276 #CAleg #Novartis #FDA #HearThisWellhttps://t.co/dM5e89yvWO
Is @Novartis faking their data to a $2M/sale product? Nice. Can we have more (enforced) openness of commercial "research" please? https://t.co/tMm956zbCc
— KordingLab (@KordingLab) August 7, 2019
Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment https://t.co/Sn6L9d2ia1
— Heikki Saxén (@heikki_saxen) August 7, 2019
Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment - The New York Times https://t.co/v87J7x0nsc
— XENIA KOUNALAKI (@xkounalaki) August 7, 2019
BREAKING NEWS: The US FDA said that data manipulation took place during the pre-clinical trial of Zolgensma, a recently approved gene therapy for children with spinal muscular atrophy, a rare and often fatal genetic disease. https://t.co/y2X4nrHd7H#genetherapy #SMA @AveXisInc pic.twitter.com/f4fm7eGuJ3
— Precision Medicine World Conference (@PMWCintl) August 7, 2019
Novartis Hid Manipulated Data While Seeking Approval for $2.1 Million Treatment https://t.co/RPIqoAJo0v
— D.K.R. Boyd (@ReflectingMan) August 7, 2019
Gene&Cell Therapy >> Published by Precision Medicine World Conference in Twitter: BREAKING NEWS: The US FDA said that data manipulation took… https://t.co/2Lv2JDoQF8 #LucidQuest #followthepatient #genetherapy #celltherapy #immunotherapy #biotech #cancer #regenerativemedicine pic.twitter.com/hUH2HbST67
— Dr Timos Papagatsias (@_timos_) August 7, 2019